Atypical pneumonia, which is caused by Mycoplasma pneumoniae, Legionella spp., Chlamydia pneumoniae, Chlamydia psittaci, and viruses, has been thought to account for 7%-20% of community-acquired pneumonia (CAP). 1 The treatment for the pathogens that cause atypical pneumonia is different from that of other bacterial pneumonia. 
| C A S E PRE S ENTATI ON
A 28-year-old healthy woman who had fever and dry cough was referred to our emergency department for evaluation of left-sided pneumonia.
Six days prior to admission, she started to have flulike symptoms and persistent fever, for which she took loxoprofen and acetaminophen.
Two days prior to admission, she consulted a clinic, where chest radiograph did not reveal any sign of infection. The day of admission, she went to another clinic for further workup and chest computed tomography (CT) showed left lung consolidation ( Figure 1A) ; thereafter, she was referred to our emergency department. She worked as a nurse at our facility without occupational exposure to chemicals or toxins. She had no prior medical problems or surgeries and denied cigarette smoking, alcohol abuse, and illicit drug use.
Physical examination showed a young woman of average built, with clear mental status, temperature of 36.6°C, pulse rate of 114 beats per minute, respiratory rate of 24 breaths per minute, blood pressure of 120/70 mm Hg, and oxygen saturation of 96% on ambient air. Air entry was distant on the left lung; there were no rales on the bilateral lungs. Heart sounds were normal, and there was no abdominal tenderness or organomegaly. The initial laboratory examination showed mild leukocytopenia (white blood cell count of 3200/mm 3 with 77.8% neutrophils) and elevated C-reactive protein 
| D ISCUSS I ON
Mycoplasma pneumoniae infection has been reported to be most common among patients younger than 50 years of age and without significant comorbid conditions. 3 However, the diagnosis of CAP was performed using rapid antigen kit, albeit the lower diagnostic sensitivity compared with the genetic method. 4 We calculated the negative likelihood ratio of Ribotest of 0.315, which might be proper value to deny the infection because of low pretest probability of M. pneumoniae infection at that time. Her initial chest radiograph and CT showed left lower lobe consolidation, which was diagnosed as bacterial CAP.
Delayed treatment with appropriate antibiotics might be one of the reasons for the occurrence of extrapulmonary manifestations of M. pneumoniae infection; in fact, cardiac, dermatologic, gastrointestinal, hematologic, musculoskeletal, neurologic, and urogenital complications reportedly occurred in up to 25% of patients. 2, 5 Hepatic and cardiac damage caused by M. pneumoniae infection was reportedly induced by a combination of autoimmunity response and inflammatory cytokines. 6 The incidence of hepatitis because of M. pneumoniae infection has been thought to be rare, 2 although it was reported to be 7.7% in Korea. 7 In this case, drug-induced hepatitis was unlikely because the hepatic enzyme levels were elevated before initiation of treatment and dropped after treatment.
However, the DLST results were positive for oral acetaminophen and loxoprofen, which should be considered as a cause of hepatitis.
However, these medicines had already been administered before hospitalization, while the liver enzymes peaked on the 8th hospital day and the onset time did not appear to match the regimen of these medicines. Therefore, we believed that the hepatitis was more likely caused by the delayed treatment. Cardiac involvement of M. pneumoniae infection is also relatively rare, with an incidence ranging between 1% and 8.5%. 2 In this case, the tachycardia and increased cardiac enzyme, which were probably associated with M. pneumoniae, gradually resolved with improvement of the respiratory symptoms.
Although our case did not meet the Infectious Diseases Society of America/American Thoracic Society criteria for severe CAP, 3 the patient might have been in a severe condition despite the fact that no pathogen was identified. Appropriate initial treatment is the key for a favorable outcome of M. pneumoniae CAP and prompt administration of appropriate antibiotics with steroids is required for severe cases. 8, 9 Although her symptoms got better with levofloxacin, we should have administered corticosteroid as a cellular immune suppressor with antibiotic treatment. We did not use macrolide first because the prevalence of macrolide-resistant M. pneumoniae remains high in Japan. 10 One study reported the prevalence of macrolideresistant M. pneumoniae in adult patients with CAP was 100%. The prevalence of azithromycin-resistant M. pneumoniae was reported 72%, and tuberculosis test was negative in this patient; thus, we chose levofloxacin instead of macrolide antibiotics. Because the patient worked at our medical facility as a nurse, we did not choose fluoroquinolone initially because M. tuberculosis was a possible etiology, and fluoroquinolone treatment might render the culture results negative and delay the diagnosis.
In conclusion, based on this experience on a case of CAP because of M. pneumoniae, delayed administration of appropriate antibiotics may contribute to development of extrapulmonary manifestations.
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